Enteral Nutrition Safety and Outcomes of Patients with COVID-19 on Continuous Infusion of Neuromuscular Blockers: A Retrospective Study

Table 3

Outcomes of the study patients.

	Nonproned N = 66	Proned N = 115	value
ICU-acquired pneumonia, N (%)	22 (37.9)	36 (31.3)	0.78
Tracheostomy, N (%)	14 (37.1)	22 (63.9)	0.74
Duration of MV, median (Q1, Q3)	13.0 (7.0, 20.0)	13.5 (8.0, 19.0)	0.87
ICU length of stay, median (Q1, Q3)	15.0 (8.5, 23.5)	17.00 (10.0, 24.0)	0.28
Hospital length of stay, median (Q1, Q3)	13.3 (22.0, 33.0)	22.0 (16.0, 34.0)	0.57
ICU death, N (%)	40 (60.6)	64 (55.6)	0.40
Hospital death, N (%)	43 (65.2)	68 (59.1)	0.32

ICU: intensive care unit, MV: mechanical ventilation, Q1: first quartile, and Q3: third quartile. Chi square test/Fisher’s exact test was done for categorical variables (significant at <0.05). Mann–Whitney test was performed for all continuous variables (significant at <0.05).